Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.

Authors :: Brun-Pascaud M
Chau F
Rajagopalan-Levasseur P
Derouin F
Girard PM
Source :: The Journal of eukaryotic microbiology [J Eukaryot Microbiol] 1996 Sep-Oct; Vol. 43 (5), pp. 14S-15S.
Publication Year :: 1996

Subjects :: Animals
Atovaquone
Drug Evaluation
Drug Therapy, Combination
Pneumocystis drug effects
Pneumonia, Pneumocystis complications
Rats
Rats, Wistar
Toxoplasma drug effects
Toxoplasmosis, Animal complications
Antifungal Agents therapeutic use
Antiprotozoal Agents therapeutic use
Naphthoquinones therapeutic use
Pneumonia, Pneumocystis prevention & control
Rifabutin therapeutic use
Toxoplasmosis, Animal prevention & control
Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use

Full Text Access

Tools